YU83403A - Korišćenje derivata piridoindolona za spravljanje lekova - Google Patents

Korišćenje derivata piridoindolona za spravljanje lekova

Info

Publication number
YU83403A
YU83403A YU83403A YUP83403A YU83403A YU 83403 A YU83403 A YU 83403A YU 83403 A YU83403 A YU 83403A YU P83403 A YUP83403 A YU P83403A YU 83403 A YU83403 A YU 83403A
Authority
YU
Yugoslavia
Prior art keywords
preparing medicines
pyridoindolone derivatives
pyridoindolone
derivatives
preparing
Prior art date
Application number
YU83403A
Other languages
English (en)
Inventor
Bernard Bourrie
Pierre Casellas
Jean-Marie Derocq
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of YU83403A publication Critical patent/YU83403A/sh
Publication of RS50790B publication Critical patent/RS50790B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

U izumu se radi o korišćenju jedinjenja formule (I) za dobijanje lekova korisnih kao antikancerozna sredstva.[The invention concerns a novel use of compounds of formula (I), wherein: r3 represents a phenyl group optionally substituted or a thienyl group, for preparing medicines useful as anticancer drugs.
YUP-834/03A 2001-04-27 2002-04-26 Korišćenje derivata piridoindolona za spravljanje lekova RS50790B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105843A FR2823975B1 (fr) 2001-04-27 2001-04-27 Nouvelle utilisation de pyridoindolone

Publications (2)

Publication Number Publication Date
YU83403A true YU83403A (sh) 2006-08-17
RS50790B RS50790B (sr) 2010-08-31

Family

ID=8862882

Country Status (34)

Country Link
US (3) US6967203B2 (sh)
EP (2) EP1385513B1 (sh)
JP (2) JP2004528343A (sh)
KR (1) KR100847413B1 (sh)
CN (2) CN1505511A (sh)
AR (1) AR034313A1 (sh)
AT (2) ATE338548T1 (sh)
BG (2) BG108260A (sh)
BR (1) BR0209138A (sh)
CA (2) CA2443012C (sh)
CY (1) CY1105813T1 (sh)
CZ (2) CZ299465B6 (sh)
DE (2) DE60214533T2 (sh)
DK (2) DK1385513T3 (sh)
EA (1) EA005930B1 (sh)
EE (2) EE200300466A (sh)
ES (2) ES2254683T3 (sh)
FR (1) FR2823975B1 (sh)
HK (2) HK1059895A1 (sh)
HU (2) HUP0400744A2 (sh)
IL (4) IL158312A0 (sh)
IS (1) IS2441B (sh)
MX (1) MXPA03009639A (sh)
NO (2) NO20034787L (sh)
NZ (1) NZ528671A (sh)
PL (2) PL366910A1 (sh)
PT (2) PT1385512E (sh)
RS (2) RS50791B (sh)
RU (1) RU2292888C9 (sh)
SK (2) SK13242003A3 (sh)
TW (1) TWI252104B (sh)
UA (1) UA74876C2 (sh)
WO (2) WO2002087574A2 (sh)
ZA (1) ZA200307785B (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846329B1 (fr) * 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
US7456193B2 (en) * 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2869316B1 (fr) * 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) * 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) * 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
SU833972A1 (ru) 1979-10-26 1981-05-30 Институт Физико-Органической Химиии Углехимии Ah Украинской Ccp Имидазо(4,5-с)пиридиний иодиды вКАчЕСТВЕ пРОМЕжуТОчНыХ пРОдуКТОВ дл СиНТЕзА фуНгицидОВ
FR2595701B1 (fr) * 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
US5035252A (en) * 1990-12-14 1991-07-30 Mondre Steven J Nicotine-containing dental floss
DE69535703T2 (de) * 1994-04-13 2009-02-19 The Rockefeller University AAV-vermittelte Zufuhr von DNA an Zellen des Nervensystems
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
FR2765582B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
WO1999051597A1 (en) * 1998-04-02 1999-10-14 Neurogen Corporation Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
IT1313592B1 (it) 1999-08-03 2002-09-09 Novuspharma Spa Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) * 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
US6958347B2 (en) 2002-12-18 2005-10-25 Pfizer Inc. Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists
FR2869316B1 (fr) 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
PT1385513E (pt) 2007-01-31
HUP0400744A2 (hu) 2004-06-28
US20040122036A1 (en) 2004-06-24
DK1385512T3 (da) 2006-05-22
WO2002087574A3 (fr) 2003-02-13
DE60214533D1 (de) 2006-10-19
HK1060066A1 (en) 2004-07-30
IL158312A0 (en) 2004-05-12
NZ528671A (en) 2004-06-25
CN1240382C (zh) 2006-02-08
RU2003130376A (ru) 2005-04-10
NO20034785D0 (no) 2003-10-24
ATE338548T1 (de) 2006-09-15
BG108261A (bg) 2004-12-30
DE60208365T2 (de) 2006-09-07
CA2444334A1 (fr) 2002-11-07
US20050272760A1 (en) 2005-12-08
RS50791B (sr) 2010-08-31
ES2254683T3 (es) 2006-06-16
EE200300465A (et) 2003-12-15
WO2002087575A1 (fr) 2002-11-07
CZ20032910A3 (en) 2004-07-14
HK1059895A1 (en) 2004-07-23
YU83903A (sh) 2006-08-17
PT1385512E (pt) 2006-05-31
FR2823975A1 (fr) 2002-10-31
MXPA03009639A (es) 2004-06-30
HUP0400745A2 (hu) 2004-08-30
CN1505511A (zh) 2004-06-16
TWI252104B (en) 2006-04-01
WO2002087574A2 (fr) 2002-11-07
KR20040015138A (ko) 2004-02-18
RU2292888C2 (ru) 2007-02-10
UA74876C2 (en) 2006-02-15
SK13252003A3 (sk) 2004-03-02
CY1105813T1 (el) 2011-02-02
CZ299465B6 (cs) 2008-08-06
EP1385512A2 (fr) 2004-02-04
FR2823975B1 (fr) 2003-05-30
NO20034787D0 (no) 2003-10-24
DK1385513T3 (da) 2007-01-15
RS50790B (sr) 2010-08-31
JP2004528343A (ja) 2004-09-16
NO20034787L (no) 2003-12-23
EP1385513B1 (fr) 2006-09-06
US7524857B2 (en) 2009-04-28
ATE314070T1 (de) 2006-01-15
US7160895B2 (en) 2007-01-09
DE60214533T2 (de) 2007-06-21
BR0209138A (pt) 2004-06-08
KR100847413B1 (ko) 2008-07-18
US6967203B2 (en) 2005-11-22
CZ20032909A3 (en) 2004-06-16
ES2271264T3 (es) 2007-04-16
SK13242003A3 (sk) 2004-03-02
US20040122027A1 (en) 2004-06-24
PL366916A1 (en) 2005-02-07
IL158312A (en) 2009-09-01
JP2004531538A (ja) 2004-10-14
EA005930B1 (ru) 2005-08-25
EE200300466A (et) 2003-12-15
IS6984A (is) 2003-10-09
PL366910A1 (en) 2005-02-07
DE60208365D1 (de) 2006-02-02
IL158266A0 (en) 2004-05-12
CN1505510A (zh) 2004-06-16
BG108260A (bg) 2004-12-30
NO20034785L (no) 2003-12-23
RU2292888C9 (ru) 2007-06-20
EP1385512B1 (fr) 2005-12-28
EA200301062A1 (ru) 2004-04-29
EP1385513A1 (fr) 2004-02-04
IL158266A (en) 2009-09-01
CA2443012A1 (en) 2002-11-07
ZA200307785B (en) 2004-10-06
CA2443012C (fr) 2009-07-28
AR034313A1 (es) 2004-02-18
CZ295224B6 (cs) 2005-06-15
IS2441B (is) 2008-11-15

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
SE0104140D0 (sv) Novel Compounds
AU2002239344A1 (en) Pyrazolopyridines
DE602004021472D1 (en) Pyrimiidinverbindungen
EP2266623A3 (en) Prodrugs containing novel bio-cleavable linkers
YU46903A (sh) Derivati difenil-azetidinona,postupak za njihovu proizvodnju lekovi koji sadrže ova jedinjenja i njihova primena
YU47803A (sh) Derivati difenil-azetidinona, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
GB0124627D0 (en) Novel compounds
NZ527867A (en) Oral pharmaceutical composition of cefpodoxime proxetil
ZA200707901B (en) Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
MY136430A (en) N-adamantylmethyl derivatives, pharmaceutical compositions containing them and processes for their preparation
MY128924A (en) Novel compounds
DE60112330D1 (en) Pyrazolopyridinderivate
ZA200604410B (en) Imidazole derivatives, processes for preparing them and their uses
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
WO2003004501A3 (en) (hetero) aryl substituted benzofurans as 5-ht ligands
WO2004087652A3 (en) Imidazotriazine compounds
MXPA03009639A (es) Uso de derivados de piridoindolona para preparar medicinas anticancer.
AU2002248531A1 (en) Pyrazolopyriadine derivatives
PL361850A1 (en) Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents